3 research outputs found
Copper and Silver Complexes of Tris(triazole)amine and Tris(benzimidazole)amine Ligands: Evidence that Catalysis of an AzideāAlkyne Cycloaddition (āClickā) Reaction by a Silver Tris(triazole)amine Complex Arises from Copper Impurities
The
synthesis and characterization of a silver complex of the tripodal
triazole ligand, trisĀ(benzyltriazolylmethyl)Āamine (TBTA, <b>L</b><sup><b>1</b></sup>), that is used as promoter to enhance Cu<sup>I</sup>-catalyzed azideāalkyne cycloaddition (CuAAC) reactions
is reported. X-ray analysis of the silverĀ(I) complex with <b>L</b><sup>1</sup> reveals a dinuclear cation, [Ag<sub>2</sub>(<b>L</b><sup><b>1</b></sup>)<sub>2</sub>]<sup>2+</sup>, that is essentially
isostructural to the copperĀ(I) analogue. While the [Ag<sub>2</sub>(<b>L</b><sup><b>1</b></sup>)<sub>2</sub>]Ā(BF<sub>4</sub>)<sub>2</sub> complex provides catalysis for the azideāalkyne
cycloaddition process, evidence is presented that this arises from
trace copper contamination. The synthesis of silverĀ(I), copperĀ(II),
and copperĀ(I) complexes of a second tripodal ligand, trisĀ(2-benzimidazolymethyl)Āamine
(<b>L</b><sup><b>2</b></sup>), which is used to enhance
the rate of CuAAC reactions, is also reported. X-ray crystallography
of the Cu<sup>I</sup> complex [Cu<sup>I</sup><sub>3</sub>(<b>L</b><sup><b>2</b></sup>)<sub>2</sub>(CH<sub>3</sub>CN)<sub>2</sub>]Ā(BF<sub>4</sub>)<sub>3</sub> offers structural insight into previous
mechanistic speculation about the role of this ligand in the CuAAC
reaction
[Re(CO)<sub>3</sub>]<sup>+</sup> Complexes of <i>exo</i>-Functionalized Tridentate āClickā Macrocycles: Synthesis, Stability, Photophysical Properties, Bioconjugation, and Antibacterial Activity
There is considerable interest in
the development of bifunctional ligand scaffolds for the group 7 metals
due to potential biological applications. Building on our recent work
in the development of āclickā ligands and macrocycles,
we show that a CuAAC āclickā approach can be exploited
for the synthesis of a small family of bioconjugated tridentate pyridyl-1,2,3-triazole
macrocycles. These bioconjugated tridentate macrocycles form stable
[ReĀ(CO)<sub>3</sub>]<sup>+</sup> complexes, and this could facilitate
the development of [MĀ(CO)<sub>3</sub>]<sup>+</sup> (M = Mn, Tc, Re)
targeted agents. The parent macrocycle, bioconjugates, and [ReĀ(CO)<sub>3</sub>]<sup>+</sup> complexes were characterized by elemental analysis
and HR-ESI-MS, <sup>1</sup>H and <sup>13</sup>C NMR, and IR spectroscopy,
and the molecular structures of the alcohol-functionalized macrocycle
and two of the ReĀ(I) complexes were confirmed by X-ray crystallography.
The electronic structure of the parent [ReĀ(CO)<sub>3</sub>]<sup>+</sup> macrocycle complex was examined using UVāvis, Raman, and
emission spectroscopy and density functional theory calculations.
The complex exhibited intense absorptions in the UV region which were
modeled using time-dependent density functional theory (TD-DFT). The
calculations suggest that the lower energy part of the absorption
band is MLCT in nature and additional higher energy ĻāĻ*
transitions are present. The complex was weakly emissive at room temperature
in methanol with a quantum yield of 5.1 Ć 10<sup>ā3</sup> and correspondingly short excited state lifetime (Ļ ā
20 ns). The family of macrocycles and the corresponding ReĀ(I) complexes
were tested for antimicrobial activity <i>in vitro</i> against
both Gram positive (Staphylococcus aureus) and Gram negative (Escherichia coli) microorganisms. Agar-based disk diffusion assays indicated that
two of the ReĀ(I) complexes displayed antimicrobial activity but the
minimum inhibitory concentrations (MIC) for these compounds proved
to be extremely modest (MIC > 256 Ī¼g/mL)
Toward Hypoxia-Selective Rhenium and Technetium Tricarbonyl Complexes
With the aim of preparing
hypoxia-selective imaging and therapeutic agents, technetiumĀ(I) and
rheniumĀ(I) tricarbonyl complexes with pyridylhydrazone, dipyridylamine,
and pyridylaminocarboxylate ligands containing nitrobenzyl or nitroimidazole
functional groups have been prepared. The rhenium tricarbonyl complexes
were synthesized with short reaction times using microwave irradiation.
Rhenium tricarbonyl complexes with deprotonated <i>p</i>-nitrophenyl pyridylhydrazone ligands are luminescent, and this has
been used to track their uptake in HeLa cells using confocal fluorescent
microscopy. Selected rhenium tricarbonyl complexes displayed higher
uptake in hypoxic cells when compared to normoxic cells. A <sup>99m</sup>Tc tricarbonyl complex with a dipyridylamine ligand bearing a nitroimidazole
functional group is stable in human serum and was shown to localize
in a human renal cell carcinoma (RCC; SK-RC-52) tumor in a mouse